JCOGP

As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance.

EndNote Style
Index
Original Article
Relationship between the use of an intrauterine device and ASC-US
Aims: Cervical cancer is one of the most common gynecological cancers and has poor outcomes. Although it is more easily detected through cervical cancer screening programs, studies on the interpretation of precancerous lesions and their future consequences are among the controversial issues in literature. Atypical squamous cells of undetermined significance (ASC-US) is a category of cervical epithelial cell abnormalities described by the Bethesda system for reporting cervical cytology. It refers to abnormal cytologic changes that suggest the squamous intraepithelial lesion (SIL) but are qualitatively and quantitatively less than those of a definitive SIL diagnosis. Only some studies about intrauterine devices (IUDs), a frequently used family planning method, and causality with ASC-US have been found in the literature. Although it is known that ASC-US may be caused by inflammation, it is not clear whether an IUD can cause it. Our study aimed to evaluate the prevalence of ASC-US in women who used or did not use IUDs and to determine the risk factors associated with IUD use.
Methods: Pregnant and lactating women, women with malignancies, hormonal intrauterine devices, vaginal infections, and patients whose cervical screening data were unavailable or diagnosis of inflammation were excluded. Cervical cancer screening results of ASC-US and normal cytologic results were included in the study.
Results: At our gynecological oncology reference center, cervical cancer screening (smear + human papillomavirus [HPV] ) was performed on 6452 patients between 2021 and 2022, and the smear result was interpreted as ASC-US in 306 (4.7%) of these patients. In patients without IUDs, the percentage of patients with negative ASC-US cytology was significantly greater (p:0.002) than that in patients with IUDs. The odds ratio was 1.75, as IUD-positive patients had a 1.75-fold risk of having positive ASC-US results.
Conclusion: IUDs cause inflammation, which results in ASC-US. In addition to preventing ASC-US formation, this risk can be reduced by 1.75 times by not using an IUD. Even if an IUD is used, the results of colposcopic examinations do not extend beyond the findings of inflammation.


1. Castellsagué X, Díaz M, Vaccarella S, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies.Lancet Oncol. 2011;12(11):1023-1031.
2. Risse EK, Beerthuizen RJ, Vooijs GP. Cytologic and histologic findings in women using an IUD.Obstet Gynecol. 1981;58(5):569-573.
3. Fornari ML. Cellular changes in the glandular epithelium of patients using IUCD--a source of cytologic error.Acta Cytol. 1974;18(4):341-343.
4. Gupta PK, Burroughs F, Luff RD, Frost JK, Erozan YS. Epithelial atypias associated with intrauterine contraceptive devices (IUD).Acta Cytol. 1978; 22(5):286-291.
5. Erdogan-Durmus S, Akalp-Ozmen S, Calik I, et al. The effects of intrauterine device on cervico-vaginal smears with liquid-based cytology technique: A North-Eastern Anatolia region study in Turkey.Afr J Reprod Health. 2022;26(1):47-52. doi:10.29063/ajrh2022/v26i1.5
6. Baris II, Keles AN. [A review on the impact of IUD in cervical cytology: Mardin region data]. Turk Patoloji Derg. 2013;29(1):51-57.
7. Buckley CH. The pathology of intra-uterine contraceptive devices.Curr Top Pathol. 1994;86:307-330. doi:10.1007/978-3-642-76846-0_8
8. Eleuterio J Junior, Giraldo PC, Silveira Gonçalves AK, Nunes Eleuterio RM. Liquid-based cervical cytology and microbiological analyses in women using cooper intrauterine device and levonorgestrel-releasing intrauterine system.Eur J Obstet Gynecol Reprod Biol. 2020;255:20-24. doi:10.1016/j.ejogrb.2020.09.051
9. Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives.Open Access J Contracept. 2018;9(1):91-112.
10. Achilles SL, Austin MN, Meyn LA, Mhlanga F, Chirenje ZM, Hillier SL. Impact of contraceptive initiation on vaginal microbiota [published correction appears in Am J Obstet Gynecol. 2021;225(4):434.
11. Orous VF, Pitman MB. Interpretation pitfalls and malignant mimics in cervical cytology.J Am Soc Cytopathol. 2021;10(2):115-127. doi:10.1016/j.jasc.2020.06.005
12. Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit.BMC Infect Dis. 2009;9(1):191.
13. Loopik DL, IntHout J, Melchers WJG, Massuger LFAG, Bekkers RLM, Siebers AG. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study.Eur J Cancer. 2020;124:102-109. doi:10.1016/j.ejca.2019.10.009
Volume 3, Issue 1, 2025
Page : 14-18
_Footer